Novo Nordisk partners with Anthropic to expand AI drug research
Novo Nordisk said it entered a partnership with Anthropic to expand AI use in drug research and software development, targeting research challenges and potentially shortening parts of medicine development.
Novo Nordisk said it has entered a partnership with Anthropic to expand the use of artificial intelligence in drug research and software development. The agreement is intended to help the Wegovy maker address key research challenges and potentially shorten parts of the medicine development process.